News & Events about Nautilus Biotechnology Inc.
SEATTLE, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the fourth quarter and full year of 2022 before market open on Thursday, ...
Proteomics company opens new office in Southern California to facilitate ongoing research and team growth aimed at unlocking the potential of the proteome
Nautilus Biotechnology - San Diego
University Town Center in San Diego, California
Nick Nelson
SVP and Chief Business Officer
SEATTLE, ...
Collaboration enables TGen to gain access to data generated on prototype versions of Nautilus next-generation proteome analysis platform to advance the study of a rare childhood cancerSEATTLE, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus), a company ...
Banzai, a Seattle marketing software startup, announced Thursday that it will go public after it agreed to merge with a special-purpose acquisition company. The company also said that it will pay $110 million to acquire marketing optimization startup Hyros after the SPAC deal closes. Founded in 2016...
Market News Video
2 months ago
In trading on Thursday, shares of Nautilus Biotechnology Inc (NAUT) touched a new 52-week low of 1.82/share. Thats a 4.47 share price drop, or -71.07% decline from the 52-week high of 6.29 set back on 12/27/2021...